D. E. Shaw & Co., Inc. Atri Cure, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $100 Billion
- Q1 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Atri Cure, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 25,355 shares of ATRC stock, worth $850,406. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,355
Previous 67,462
62.42%
Holding current value
$850,406
Previous $2.06 Million
60.36%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding ATRC
# of Institutions
238Shares Held
52MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$158 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$155 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$123 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$101 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$81.7 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.56B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...